According to Smith & Nephew
's latest financial reports the company has $0.35 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.35 B | -72.87% |
2021-12-31 | $1.29 B | -26.79% |
2020-12-31 | $1.76 B | 536.1% |
2019-12-31 | $0.27 B | -24.11% |
2018-12-31 | $0.36 B | 115.98% |
2017-12-31 | $0.16 B | 69% |
2016-12-31 | $0.10 B | -16.67% |
2015-12-31 | $0.12 B | 29.03% |
2014-12-31 | $93 M | -32.12% |
2013-12-31 | $0.13 B | -23.03% |
2012-12-31 | $0.17 B | -3.26% |
2011-12-31 | $0.18 B | -11.11% |
2010-12-31 | $0.20 B | 7.81% |
2009-12-31 | $0.19 B | 32.41% |
2008-12-31 | $0.14 B | -14.71% |
2007-12-31 | $0.16 B | -50.87% |
2006-12-31 | $0.34 B | 293.18% |
2005-12-31 | $88 M | 40.8% |
2004-12-31 | $62.5 M | 34.62% |
2003-12-31 | $46.42 M | 28.05% |
2002-12-31 | $36.25 M | -17% |
2001-12-31 | $43.68 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $23.51 B | 6,619.71% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | $0.92 B | 165.14% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $1.25 B | 258.34% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $1.75 B | 402.00% | ๐บ๐ธ USA |
![]() Orthofix Medical
OFIX | $50.7 M | -85.51% | ๐บ๐ธ USA |
![]() CONMED CNMD | $28.94 M | -91.73% | ๐บ๐ธ USA |